Search

everythinglearnresearchcommunity

for

Search:↓

New biomarkers and potential treatments for skin diseases were identified.

Regenerative treatments for vitiligo show promise but need more research for long-term safety and effectiveness.

Mesenchymal stem cells could help treat diabetes and its complications by improving insulin function and reducing inflammation.

Changes in genes FGA, VWF, and ACTG1 may contribute to pemphigus vulgaris.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Alopecia areata involves immune system issues and specific cell types that disrupt hair growth, leading to hair loss.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Plerixafor may help treat pigmentation disorders by promoting skin repigmentation.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

PRP may help with aging and osteoarthritis, improving tissue repair and reducing surgery risk.

Women with PCOS have a higher risk of heart disease.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Unique microRNA patterns can help diagnose and treat severe alopecia areata.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Certain genes may be linked to autoimmune conditions in people with alopecia areata.

Enterococcus faecalis delays wound healing by disrupting cell functions and creating an anti-inflammatory environment.

Plucking some hairs can trigger nearby unplucked hairs to grow back more due to a collective response.

Chemistry42 effectively creates and optimizes new molecules for drug discovery.

Alopecia areata is caused by an immune response, and targeting immune cells might help treat it.

Vitamin D may help reduce thyroid antibodies and improve thyroid function in Hashimoto's Thyroiditis.

Removing senescent cells can improve hair growth and regeneration.

Alopecia areata patients don't have increased atherosclerosis risk, but may have higher cardiovascular risk due to smoking, blood sugar, and blood pressure.

Engineering strategies improve stem cells' ability to heal wounds effectively.

CD44 signaling can help heal wounds without scars.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Triphenylphosphine oxide can increase oil production and reduce inflammation in skin cells without affecting TRPM5.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.